Schroders Capital Overview
- Founded
- 1997
- Status
- Acquired/Merged
- Employees
- 500
- Latest Deal Type
- M&A
- Financing Rounds
- 1
- Investments
- 70
Schroders Capital General Information
Description
Provider of asset management services intended to offer specialized investment services. The company's asset management services include private equity investment management, fund investment, specialized strategies and segments within private equity, such as small and mid-sized buyouts, early stage venture capital, growth capital and turnarounds, enabling clients such as venture capital, buyouts, co-investments, pension funds, insurance companies, endowments, family offices and other financial institutions to access select private market segments through primary, secondary and direct or co-investments.
Contact Information
Website
www.schroderscapital.com
Formerly Known As
Adveq Management
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- Affolternstrasse 56
- 8050 Zurich
- Switzerland
+41 058 000 00 00
Schroders Capital Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Schroders Capital‘s full profile, request access.
Request a free trialSchroders Capital Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of asset management services intended to offer specialized investment services. The company's asset management
Asset Management
Zurich, Switzerland
500
As of 2022
000000&0
00000000
minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Du
0000000 000000
London, United Kingdom
000
As of 0000
00000000
00000000
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore
0000000 000000
Amsterdam, Netherlands
000
As of 0000
0000
0000-00-00
00000000000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialSchroders Capital Competitors (6)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Pantheon Ventures | Formerly PE-Backed | London, United Kingdom | 000 | 00000000 | ||
| 000000000 00000000 | Corporate Backed or Acquired | Amsterdam, Netherlands | 000 | 00000000000 | ||
| 000000000 | Corporation | New York, NY | 00000 | 00000 | 00000000000 | 00000 |
| 00 0000000000 0000 | Private Equity-Backed | Boston, MA | 000 | 00000000000 | ||
| 000000000 000000 | Formerly PE-Backed | New York, NY | 0000 | 00000 | 00000000 |
Schroders Capital Executive Team (75)
Schroders Capital Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000 0000000 | Schroders Capital | Founder & Non-executive Vice Chairman | 000 0000 |
| 0000 0000 00.0 | Schroders Capital | Chief Investment Officer & Management Committee and Investment Committee Member | 000 0000 |
| 000000 00000 00.0 | Schroders Capital | Head of Private Equity & Investment Committee Member | 000 0000 |
| 0000000 00000 | Schroders Capital | Executive Chairman | 000 0000 |
| 000 00000 | Schroders Capital | Head of Investments Europe & Investment Committee Member | 000 0000 |
Schroders Capital Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialSchroders Capital Investments (70)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000 | 02-Mar-2022 | 00000 0000 | 000.00 | Drug Discovery | |
| 0000 00000000 | 16-Feb-2022 | 00000 0000 | 0000 | Drug Discovery | |
| 000 000000 | 10-Feb-2022 | 00000 0000 | 00000 | Enterprise Systems (Healthcare) | 00000 000 |
| 0000 00000000 | 09-Feb-2022 | 0000 00000 | 000.00 | Drug Discovery | |
| Eikon Therapeutics | 06-Jan-2022 | Early Stage VC | 00000 | Drug Discovery |
Schroders Capital Exits (17)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 0000000 0000000000 | 06-Jul-2020 | 00000 00000 00 | 000.00 | Completed |
|
| 0000 000000000000 | 28-Feb-2020 | 00000 00000 00 | Completed |
|
|
| 000000 00000000000 | 27-Feb-2020 | 00000 00000 00 | 00000 | Completed |
|
| 0000000000 0000000 | 09-Jul-2019 | 00000 00000 00 | 00000 | Completed |
|
| Amal Therapeutics | 12-Nov-2018 | Later Stage VC | 000.00 | Completed |
|